T1	condition 53 62	Bone Loss
T2	eligibility 392 411	Premenopausal women
T3	total-participants 417 420	206
T4	age 426 436	≤ 55 years
T7	control 570 583	control group
T6	intervention 263 303	combined aerobic and resistance exercise
T11	outcome 1262 1293	Bone turnover markers decreased
T12	total-participants 1084 1087	100
T13	control-participants 1089 1091	54
T14	intervention-participants 1101 1103	46
T17	outcome 1151 1173	lumbar spine bone loss
T5	eligibility 437 517	at cancer diagnosis who were within two years of receiving adjuvant chemotherapy
T8	outcome 827 843	Lumbar spine BMD
T9	iv-cont-mean 935 942	-0.008 
T10	iv-cont-mean 944 955	0.003 g/cm2
T15	cv-cont-mean 969 975	-0.014
T16	cv-cont-sd 978 989	0.003 g/cm2
T18	iv-cont-mean 1175 1180	0.001
T20	iv-cont-sd 1183 1194	0.005 g/cm2
T19	cv-cont-mean 1215 1221	-0.014
T21	cv-cont-sd 1224 1235	0.005 g/cm2
